— · Drug Manufacturers - Specialty & Generic

Optimi Health Corp. (OPTH) Stock

$4.02 -1.59% —: OPTH Healthcare

Valuation

MetricValue
Price$4.02
Market Cap$12.95M
P/E Ratio-3.28
P/B Ratio1.56
P/S Ratio117.32
EPS (TTM)$-1.16
52-Week High$8.84
52-Week Low$4.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-84.23%
ROA-26.68%
ROCE-35.76%
Gross Margin-12.96%
Operating Margin-24.02%
Net Margin-20.70%
Debt/Equity0.29
Current Ratio0.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-6.0M$-7.0M$-4.0M$-6.0M$-5.0M
Net Profit$-6.0M$-7.0M$-5.0M$-6.0M$-4.0M
EPS$-0.12$-2.70$-1.79$-2.02$-1.16
Op Margin—-9155.2%-2419.1%-1438.8%-1062.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$23.0M$17.0M$16.0M$15.0M$15.0M
Total Liabilities$2.0M$1.0M$3.0M$5.0M$9.0M
Cash$8.0M$2.0M$1.0M$0$1.0M
Borrowings$0$0$2.0M$3.0M$7.0M

Latest News

3 Psychedelic Stocks With Potential Clinical Trial Catalysts Simply Wall St. · Jul 10, 2026 Weekly Roundup on the Cannabis Sector & Psychedelic Sector Market Exclusive · Jul 6, 2026 Optimi Health Makes Third Commercial Shipment of Psilocybin for Treatment-Resistant Depression to Australia MT Newswires · Jun 29, 2026 Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression PR Newswire · Jun 29, 2026 Optimi Health Completes Third Psilocybin Export to Australia MT Newswires · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-6.0M$-5.0M$-4.0M$-4.0M$-3.0M
Investing Cash Flow$-14.0M$-10.0M$-2.0M$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$4.0M$-7.0M$-1.0M$-1.0M$1.0M
Free Cash Flow$-11.0M$-12.0M$-4.0M$-4.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.07
EV / EBITDA-2.57
FCF Yield-25.76%
Quick Ratio1.69
Interest Coverage-6.42
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held0.60%
Institutions Held8.78%
Institutions Float Held8.83%
Institutional HolderSharesReport Date
AdvisorShares Trust-AdvisorShares Psychedelics ETF102,7942026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
MOOD.CNDoseology Sciences Inc. $0.12 +0.00% -1.12 $961394 0.00%
PSYC.CNPsyched Wellness Ltd. $0.01 +0.00% -0.50 $4.08M 0.00%

About Optimi Health Corp.

Optimi Health Corp. is led by CEO Dane Stevens, employs 6 people, headquartered in CA, publicly traded since 2026.

Optimi Health Corp. (OPTH) stock trades at $4.02 with a market capitalization of $12.95M. The stock is valued at a price-to-earnings (P/E) ratio of -3.28, price-to-book of 1.56, price-to-sales of 117.32. Over the past 52 weeks the stock has ranged between $4.00 and $8.84, and currently trades 54.5% below its 52-week high.

On profitability, Optimi Health Corp. generates a return on equity (ROE) of -84.23%, return on capital employed of -35.76%, an operating margin of -24.02%, a net profit margin of -20.70%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides